Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US6306437A · kind A · utility
20Cited by
19References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2000 |
| Grant date | Oct 23, 2001 |
| Priority date | — |
| Expiry date | Jun 29, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Psychogenic impotence can be ameliorated without substantial undesirable side effects by administration of apomorphine and an antiemetic agent in an amount sufficient to substantially reduce nausea symptoms associated with the use of apomorphine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.